Promegapoietin

Promegapoietin is a drug given during chemotherapy to increase blood cell regeneration. It is a colony-stimulating factor that stimulates megakaryocyte production.^[1][2]

Additional recommended knowledge

Better weighing performance in 6 easy steps

Essential Laboratory Skills Guide

Guide to balance cleaning: 8 simple steps

It functions by stimulating ligands for interleukin 3 and c-Mpl.^[3]

References

1. ^ Kratz-Albers K, Scheding S, Möhle R, Bühring H, Baum C, Mc Kearn J, Büchner T, Kanz L, Brugger W (2000). "Effective ex vivo generation of megakaryocytic cells from mobilized peripheral blood CD34(+) cells with stem cell factor and promegapoietin". Exp Hematol 28 (3): 335-46. PMID 10720698.
2. ^ http://www.cancer.gov/Templates/db_alpha.aspx?CdrID=46019
3. ^ Doshi P, Giri J, Abegg A, Favara J, Huynh M, Kahn L, Minnerly J, Pegg L, Villani-Price D, Siegel N, Staten N, Thomas J, McKearn J, Smith W (2001). "Promegapoietin, a family of chimeric growth factors, supports megakaryocyte development through activation of IL-3 and c-Mpl ligand signaling pathways". Exp Hematol 29 (10): 1177-84. PMID 11602319.